From: Is platelet transfusion associated with hospital-acquired infections in critically ill patients?
Variables | All patients N = 18,965 | Patients with PLT transfusion N = 2250 | Patients without PLT transfusion N = 16,715 | P value |
---|---|---|---|---|
Age, years, mean (SD) | 60 (18) | 59 (17) | 60 (17) | 0.04 |
Gender, male, n (%) | 12 086 (63.7%) | 1 511 (67.2%) | 10 575 (63.3%) | <0.01 |
APACHE III score, mean (SD) | 54 (26) | 65 (29) | 52 (25) | <0.01 |
Comorbidities | ||||
Any known comorbidity | 3 838 (20%) | 702 (31%) | 3 136 (19%) | <0.01 |
Cancera | 857 (4.5%) | 192 (8.5%) | 665 (4.0%) | <0.01 |
Hepatic diseaseb | 674 (3.6%) | 216 (9.6%) | 458 (2.7%) | <0.01 |
Immunocompromisedc | 1 180 (6.2%) | 311 (13.8%) | 869 (5.2%) | <0.01 |
IDDM | 511 (2.7%) | 60 (2.7%) | 451 (2.7%) | 0.93 |
Chronic respiratory disease | 840 (4.4%) | 92 (4.1%) | 748 (4.5%) | 0.40 |
CVD | 754 (4%) | 137 (6.1%) | 617 (3.7%) | <0.01 |
Chronic renal failure | 422 (2%) | 59 (2.6%) | 363 (2.2%) | 0.17 |
Admission diagnosis | ||||
Cardiovascular | 5 161 (27%) | 701 (31%) | 4 460 (27%) | <0.01 |
Gastrointestinal | 3 595 (19%) | 581 (26%) | 3 014 (18%) | <0.01 |
Haematological | 152 (0.8%) | 96 (4.3%) | 56 (0.3%) | <0.01 |
Neurological | 1 586 (8.4%) | 108 (4.8%) | 1 478 (8.8%) | <0.01 |
Renal/genitourinary | 1 017 (5.4%) | 108 (4.8%) | 909 (5.4%) | 0.2 |
Respiratory | 1 467 (7.7%) | 127 (5.6%) | 1 340 (8%) | <0.01 |
Sepsis | 503 (2.7%) | 73 (3.2%) | 430 (2.6%) | 0.06 |
Otherd | 2 815 (14.8%) | 82 (3.6%) | 2 733 (16.4%) | <0.01 |
Trauma | 2 669 (14.1%) | 374 (16.6%) | 2 295 (13.7%) | <0.01 |
Requirement for MV | 11 531 (61%) | 1 952 (87%) | 9 579 (57%) | <0.01 |
Requirement for RRT | 1 135 (6%) | 449 (20%) | 686 (4%) | <0.01 |